Immune checkpoint inhibitors for the treatment of melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitors for the treatment of melanoma

Published:2022-02-13 Issue:5 Volume:22 Page:563-576
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Sabbatino Francesco¹,Liguori Luigi²^ORCID,Pepe Stefano¹,Ferrone Soldano³

Affiliation:

1. Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana,’ University of Salerno, Salerno, Italy

2. Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Naples, Italy

3. Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

Funder

no funding associated

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2022.2038132

Reference176 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. Melanoma: chemotherapy

3. Survival of patients with advanced metastatic melanoma: The impact of novel therapies

4. Releasing the Brakes on Cancer Immunotherapy

5. Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary management of ulcerative colitis complicated by immune checkpoint inhibitor-associated colitis with life-threatening gastrointestinal hemorrhage: A case report;World Journal of Gastrointestinal Surgery;2024-07-27

2. Changes in mucosa‑associated lymphoid tissue 1 predicts therapeutic response and survival in patients with advanced melanoma receiving programmed cell death‑1 inhibitor monotherapy;Oncology Letters;2024-07-12

3. Patient-derived melanoma models;Pathology - Research and Practice;2024-07

4. Immunomodulatory Precision: A Narrative Review Exploring the Critical Role of Immune Checkpoint Inhibitors in Cancer Treatment;International Journal of Molecular Sciences;2024-05-17

5. T cell-mediated tumor killing based signature to predict the prognosis and immunotherapy for glioblastoma;Heliyon;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3